{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:04:45Z","timestamp":1774073085284,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:00:00Z","timestamp":1661644800000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jfo.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T11:58:27Z","timestamp":1625745507000},"page":"968-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Injection intravitr\u00e9enne de clindamycine dans le traitement des r\u00e9tinochoro\u00efdites toxoplasmiques\u00a0: \u00e0 propos de 9\u00a0cas dans le service d\u2019ophtalmologie du CHU de Bordeaux"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1082-5343","authenticated-orcid":false,"given":"A.","family":"Handaye-Dessus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gattoussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4438-9535","authenticated-orcid":false,"given":"J.-F.","family":"Korobelnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-N.","family":"Delyfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-B.","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2021.04.001_bib0110","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2021.04.001_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","article-title":"Causes of Uveitis in the General Practice of Ophthalmology","volume":"121","author":"McCannel","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"49","author":"Jones","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfo.2021.04.001_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1590\/S0074-02762009000200030","article-title":"Ocular toxoplasmosis: an update and review of the literature","volume":"104","author":"Commodaro","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jfo.2021.04.001_bib0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08820530500231961","article-title":"Toxoplasmosis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0135","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bjo.82.11.1306","article-title":"Azithromycin for ocular toxoplasmosis","volume":"82","author":"Rothova","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","article-title":"A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis","volume":"134","author":"Bosch-Driessen","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for Ocular Toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/infdis\/164.1.170","article-title":"Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii","volume":"164","author":"Huskinson-Mark","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfo.2021.04.001_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis","volume":"114","author":"Halonen","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090203","article-title":"Toxoplasmosis \u2013 A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88\u00a0Countries","volume":"9","author":"Flegr","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jfo.2021.04.001_bib0165","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/09273948.2011.608915","article-title":"Therapy for Ocular Toxoplasmosis","volume":"19","author":"de-la-Torre","year":"2011","journal-title":"Ocular Immunol Inflamm"},{"key":"10.1016\/j.jfo.2021.04.001_bib0170","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.clinthera.2008.10.021","article-title":"Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review","volume":"30","author":"Iaccheri","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jfo.2021.04.001_bib0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R D"},{"key":"10.1016\/j.jfo.2021.04.001_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1006129422690","article-title":"Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine","volume":"22","author":"Martinez","year":"1998","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3928\/1542-8877-20010501-03","article-title":"Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis","volume":"32","author":"Kishore","year":"2001","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.jfo.2021.04.001_bib0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/IAE.0b013e31804b3f0d","article-title":"Intravitreal clindamycin for toxoplasmic retinochoroiditis","volume":"27","author":"Sobrin","year":"2007","journal-title":"Retina (Philadelphia, Pa)"},{"key":"10.1016\/j.jfo.2021.04.001_bib0195","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A Controlled Retrospective Study of Ganciclovir Treatment for Cytomegalovirus Retinopathy: Use of a Standardized System for the Assessment of Disease Outcome","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2021.04.001_bib0200","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ophtha.2010.01.028","article-title":"Intravitreal Clindamycin and Dexamethasone for Zone 1\u00a0Toxoplasmic Retinochoroiditis at Twenty-four Months","volume":"117","author":"Lasave","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.04.001_bib0205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.04.001_bib0105","doi-asserted-by":"crossref","first-page":"e4160837","DOI":"10.1155\/2018\/4160837","article-title":"Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study","volume":"2018","author":"Bor\u2019i","year":"2018","journal-title":"J Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122100293X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122100293X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:16:23Z","timestamp":1759259783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155122100293X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S018155122100293X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2021.04.001","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injection intravitr\u00e9enne de clindamycine dans le traitement des r\u00e9tinochoro\u00efdites toxoplasmiques\u00a0: \u00e0 propos de 9\u00a0cas dans le service d\u2019ophtalmologie du CHU de Bordeaux","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}